Back to search

Article

DAS28-P Index as a Discriminatory Measure of Poor Subjective Response to Disease-Modifying Rheumatic Drug Therapy in Early Rheumatoid Arthritis

2022-03-10

Abstract excerpt

<h4>Background: </h4> The DAS28-P index, defined as the proportion of patient-reported components (joint tenderness and visual analogue scale) of the Disease Activity Score in 28 joints (DAS28), has been proposed as a useful discriminatory measure of central pain mechanisms in RA. This study aimed to evaluate the use of the DAS28-P index as a predictor of poor subjective response in early rheumatoid arthritis (RA)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8e0b20d5-5c03-5109-aff6-924da4cae9ed
DOI
10.21203/rs.3.rs-1405966/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
DAS28-P Index as a Discriminatory Measure of Poor Subjective Response to Disease-Modifying Rheumatic Drug Therapy in Early Rheumatoid ArthritisDOI 10.21203/rs.3.rs-1405966/v1
Clinical phenotype with high risk for initiation of biologic therapy in rheumatoid arthritis: a data-driven cluster analysis.Semantic proximity
Prediction of Response to Targeted Treatment in Rheumatoid Arthritis.Semantic proximity
Can alternative means of phenotyping rheumatoid arthritis reduce its apparent heterogeneity? A comparison of three disease activity classifications with DAS28.Semantic proximity
Neither ultrasound synovitis nor clinical-ultrasound phenotypes of established rheumatoid arthritis predict response to targeted therapy.Semantic proximity
Peripheral blood cellular dynamics of Rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugsSemantic proximity
Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study Registry.Semantic proximity
Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past two decades: results from a Japanese prospective observational cohort: IORRASemantic proximity
Peripheral and central contributions to persistent pain in rheumatoid arthritis: an unbiased latent profile analysis identifies four mechanism-based phenotypesSemantic proximity
Differences and Similarities in Clinical and Functional Responses Among Patients Receiving Tofacitinib Monotherapy, Tofacitinib Plus Methotrexate, and Adalimumab Plus Methotrexate: A Post-hoc Analysis of Data From Oral StrategySemantic proximity
Secukinumab leads to shifts from stage-based towards response-based disease clusters- Comparative data from very early and established psoriatic arthritisSemantic proximity
How to Define Boolean Low Disease Activity in Rheumatoid Arthritis: Experience from a Large Real-World CohortSemantic proximity
Role of specialized pro-resolving mediators on inflammation, cardiometabolic health, disease progression, and quality of life after omega-3 PUFA supplementation and aerobic exercise training in individuals with rheumatoid arthritis: a randomized 16-week, placebo-controlled interventional trial *Semantic proximity
Select a neighboring publication to make it the new centre.